Shivali Gulab
Chief Executive
Cancer
Avaliaimmuno Therapies
New Zealand
Biography
New York based, Dr. Gulab has over nine years experience in research, the development of preÂclinical assets and partnering of novel candidates developed by leading research groups in NZ and the USA. She routinely leads negotiations with global partners that generate successful partnerships and deliver preÂclinical assets targeting a range of indications. Dr Gulab authored a number of peer reviewed papers during her tenure as Senior Scientist at the Ferrier Research Institute of Victoria University. She is a named inventor on granted US patents which have resulted in significant returns to the licensee. Dr Gulab has a PhD in chemistry and bachelor degrees in management, marketing and chemistry.
Research Interest
Cancer
